Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

The HELP-A study is a multicenter, randomized, controlled trial. A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month. This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.

The HELP-A study is a multicenter, randomized, controlled trial designed to compare the diagnostic yield, arrhythmia detection rate, user convenience, and cost-effectiveness of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms. The study enrolls patients who have symptoms suggestive of arrhythmia but remain undiagnosed on a 12-lead ECG and require additional testing. A total of 588 patients will be enrolled during the 4-year enrollment period and followed for 3 months. Patients will be randomly assigned to either a continuous patch ECG or an intermittent handheld ECG and monitored for one month. If no diagnosis is made after one month, patients will cross over to the other device and be monitored for an additional month.

Inclusion Criteria:

• Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
• Patients who can use a smartphone

Exclusion Criteria:

• Patients who have cardiac implantable electronic devices(CIEDs)
• Patients who can't use handheld ECG
• Patient who had syncope